Endoscopic submucosal injection of a synthesized anti-CHST15 dsRNA for sulfated glycosaminoglycan is a safe and beneficial treatment for patients with Crohn’s disease who do not respond sufficiently to the conventional treatment.
Endoscopic submucosal injection of a synthesized anti-CHST15 dsRNA for sulfated glycosaminoglycan is a safe and beneficial treatment for patients with Crohn’s disease who do not respond sufficiently to the conventional treatment.
复制标题
对于对常规治疗反应不足的克罗恩病患者，内镜粘膜下注射合成的硫酸化糖胺聚糖抗 CHST15 dsRNA 是一种安全且有益的治疗方法。
DOI：
--
复制
发表时间：
2014
期刊：
影响因子：
--
通讯作者：
Yoneyama Hiroyuki.
中科院分区：
文献类型：
--
作者：
Suzuki K;Yokoyama J;Kawauchi Y;Honda Y;Asakura H;Okazaki K;Suzuki Y; Sameshima Y;Fukushima T;Fujii M;Hashiguchi T;Mizumoto S;Sugahara K;Yoneyama Hiroyuki.
